CNMD — CONMED Corp
—
NYSE ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 816956 ·
Last close
$48.39
Market Cap
$1.44B
52W High
$54.80
52W Low
$31.44
ADV30
405,982
Next earnings
2027-01-27
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 335,557,000 | 189,148,000 | 37,144,000 | 19,796,000 | 2,304,462,000 | 47,972,000 | 1,244,543,000 |
| Jun 2026 | 343,488,000 | 197,458,000 | 36,405,000 | 23,071,000 | 2,300,306,000 | 37,328,000 | 1,258,916,000 |
| Mar 2026 | 317,046,000 | 183,447,000 | 25,415,000 | 13,828,000 | 2,314,942,000 | 35,030,000 | 1,297,269,000 |
| Dec 2025 | 373,198,000 | 218,285,000 | 36,624,000 | 16,739,000 | 2,325,749,000 | 40,817,000 | 1,292,652,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$150,588,000
Investing CF
$3,376,000
Financing CF
$-149,682,000
CapEx
$-16,124,000
Dividends Paid
$-12,380,000
Buybacks
$-43,221,000
EPS Diluted TTM
$1.85
As of
2026-11-01
Balance + Analyst (yfinance extras)
Retained Earnings
$625,665,000
Inventory
$360,179,000
Receivables
$239,770,000
ST Investments
—
EBIT TTM
$113,148,000
Pretax Income TTM
$83,228,000
Interest Exp TTM
$29,920,000
Analysts
6
Yahoo Snapshot (yfinance, live)
Total Revenue
$1,369,287,936
EBITDA
$214,966,000
Free Cash Flow
$107,014,128
Enterprise Value
$2,087,883,136
Total Cash
$47,972,000
Total Debt
$815,865,984
Shares Out
29,803,323
Trailing EPS
$1.85
Book Value
$34.73
ROE
7.1%
ROA
3.8%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 1,374,724,000 | 102,622,000 | 47,055,000 | 2,325,749,000 | 1,292,652,000 | 1,033,097,000 | 170,689,000 |
| Dec 2024 | 1,307,015,000 | 200,326,000 | 132,423,000 | 2,306,247,000 | 1,343,566,000 | 962,681,000 | 166,968,000 |
| Dec 2023 | 1,244,744,000 | 120,603,000 | 64,459,000 | 2,300,021,000 | 1,465,799,000 | 834,222,000 | 125,348,000 |
| Dec 2022 | 1,045,472,000 | 70,054,000 | -80,582,000 | 2,297,592,000 | 1,552,047,000 | 745,545,000 | 33,365,000 |
TTM Snapshot
Revenues TTM
$1,371,657,000
NetIncome TTM
$56,497,000
OpCashFlow TTM
—
Assets (Latest)
$2,300,306,000
Forward EPS
$4.78
Max Pain — expiry 2026-12-18 (volume-derived — Yahoo OI feed degraded)
max pain strike: $45.00 · spot: $48.01 · call volume: 17 · put volume: 13
Expected Move to 2026-12-18:
±$2.70
(5.62%) —
implied range
$45.31 –
$50.71
· ATM straddle on $50.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| BFLY | Butterfly Network, Inc. | $1.41B | $5.75 | — |
| CDRE | Cadre Holdings, Inc. | $1.39B | $32.41 | — |
| PRCT | PROCEPT BioRobotics Corp | $1.37B | $23.78 | — |
| ENOV | Enovis CORP | $1.57B | $27.22 | — |
| NVCR | NovoCure Ltd | $1.30B | $11.14 | — |
News headlines (Yahoo Finance, 1h cache)
Here's Why You Should Retain CONMED Stock in Your Portfolio for Now
2026-11-12 10:54 · Yahoo
CONMED (CNMD) Stock Looks Like A Bargain Despite Its 65% Fall
2026-11-07 09:11 · Yahoo
CNMD Q3 deep dive: stable revenue, margin improvement, and focus on core growth platforms
2026-11-03 05:01 · Yahoo
CONMED Corporation to Participate in the Jefferies Global Healthcare Conference
2026-11-02 21:05 · Yahoo
The top 5 analyst questions from CONMED’s Q3 earnings call
2026-10-31 19:39 · Yahoo
CONMED (CNMD) Shares Dropped, So What Is Going On?
2026-10-31 09:12 · Yahoo
CONMED Corporation Q3 2026 Earnings Call Summary
2026-10-29 12:30 · Yahoo
CONMED Q3 Earnings Call Highlights
2026-10-29 07:04 · Yahoo
CONMED (CNMD) Q3 2026 Earnings Call Transcript
2026-10-29 04:43 · Yahoo
Conmed (CNMD) Q3 Earnings Top Estimates
2026-10-28 22:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.